Publications by MBiostat Mark Tacey

Publications by authors named "MBiostat Mark Tacey"

J Contemp Brachytherapy

February 2024

- The study evaluated the effectiveness and safety of low-dose-rate (LDR) brachytherapy using iodine-125 for young men under 60 with localized low- to intermediate-risk prostate cancer, amid existing concerns among urologists about long-term control and side effects.
- A total of 161 patients were analyzed over a median follow-up period of 6.8 years, revealing an impressive biochemical progression-free survival rate of 94% at 8 years and an overall survival rate of 96.9%.
- The treatment resulted in minimal severe toxicities, with only 1.9% of patients developing secondary cancers, indicating that LDR brachytherapy could be a highly effective and safe option for younger men diagnosed

- Mark Tacey's recent research focuses on the effects and long-term outcomes of low-dose-rate brachytherapy in men under 60 years old diagnosed with low- to intermediate-risk prostate cancer.
- The study evaluates treatment results from a group of patients treated with iodine-125 brachytherapy, aiming to address ongoing controversies regarding treatment efficacy and associated toxicities in younger demographics.
- Findings suggest that LDR brachytherapy may serve as a viable treatment option for this age group, contributing valuable data to the ongoing discourse in urology regarding the management of localized prostate cancer.